Neuroleptic malignant syndrome in a patient with moderate intellectual disability treated with olanzapine: A case report
2021
We report the case of a 31 years old woman with moderate Intellectual Disability (ID) and Bipolar Affective Disorder who developed Neuroleptic Malignant Syndrome (NMS) after being treated with Olanzapine. Following discontinuation of the Olanzapine, she made a rapid and full recovery.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
25
References
0
Citations
NaN
KQI